We are live on
!
Find out more
SM
SG3 Management Portfolio holdings
AUM
$6.45K
1-Year Est. Return
61.81%
This Fund
S&P 500
This Quarter
Est. Return
+9.09%
1 Year Est. Return
-61.81%
3 Year Est. Return
-38.3%
5 Year Est. Return
-6.2%
10 Year Est. Return
–
AUM
$4B
AUM Growth
-$1.25B
(-24%)
Cap. Flow
-$1.28B
Cap. Flow
% of AUM
-32.02%
Top 10 Holdings %
Top 10 Hldgs %
20.82%
Holding
1,612
New
626
Increased
195
Reduced
208
Closed
487
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jazz Pharmaceuticals
JAZZ
|
+$10.2M |
| 2 |
PARA
Paramount Global Class B
PARA
|
+$6.08M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$5.95M |
| 4 |
Biogen
BIIB
|
+$5.94M |
| 5 |
Aon
AON
|
+$5.61M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$294M |
| 2 |
Lennar Class A
LEN
|
+$76.3M |
| 3 |
RH
RH
|
+$25.1M |
| 4 |
ARK Genomic Revolution ETF
ARKG
|
+$22.5M |
| 5 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$22.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 1.79% |
| 2 | Communication Services | 1.57% |
| 3 | Technology | 1.13% |
| 4 | Consumer Discretionary | 1.05% |
| 5 | Financials | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
CALL
Yeti Holdings
YETI
$3.87B
| $1.44M | 0.04% |
20,000
| – | – |
|
|
RBAC
502
DELISTED
RedBall Acquisition Corp.
RBAC
| $1.44M | 0.04% |
+144,197
| New | +$1.52M |
|
503
PUT
Plug Power
PLUG
$2.65B
| $1.43M | 0.04% |
+40,000
| New | +$2.06M |
|
|
AMRS
504
CALL
DELISTED
Amyris Inc.
AMRS
| $1.43M | 0.04% |
+75,000
| New | +$1.09M |
|
505
Gold Fields
GFI
$28.8B
| $1.42M | 0.04% |
+150,000
| New | +$1.4M |
|
|
TGNA
506
DELISTED
TEGNA Inc
TGNA
| $1.41M | 0.04% |
+75,000
| New | +$1.31M |
|
507
BioMarin Pharmaceuticals
BMRN
$11.9B
| $1.4M | 0.04% |
18,600
-17,365
| -48% | -$1.42M |
|
508
PUT
Hartford Financial Services
HIG
$39.9B
| $1.4M | 0.04% |
+21,000
| New | +$1.13M |
|
509
CALL
DaVita
DVA
$15.5B
| $1.4M | 0.04% |
+13,000
| New | +$1.44M |
|
510
PUT
Lucid Motors
LCID
$3.11B
| $1.39M | 0.03% |
+6,000
| New | +$1.6M |
|
511
CALL
Accenture
ACN
$106B
| $1.38M | 0.03% |
5,000
| – | – |
|
512
CALL
Match Group
MTCH
$9.19B
| $1.37M | 0.03% |
+10,000
| New | +$1.5M |
|
|
IPOD
513
CALL
DELISTED
Social Capital Hedosophia Holdings Corp. IV
IPOD
| $1.37M | 0.03% |
+125,000
| New | +$1.78M |
|
514
PUT
United Microelectronic
UMC
$42.9B
| $1.37M | 0.03% |
+150,000
| New | +$1.39M |
|
515
CALL
Kratos Defense & Security Solutions
KTOS
$8.23B
| $1.35M | 0.03% |
+49,500
| New | +$1.39M |
|
516
Canadian Solar
CSIQ
$932M
| $1.34M | 0.03% |
27,000
+10,250
| +61% | +$530K |
|
517
PUT
Applied Materials
AMAT
$347B
| $1.34M | 0.03% |
+10,000
| New | +$1.1M |
|
518
NVIDIA
NVDA
$4.6T
| $1.33M | 0.03% |
+100,000
| New | +$1.34M |
|
519
PUT
Kinross Gold
KGC
$27.7B
| $1.33M | 0.03% |
200,000
| – | – |
|
520
PUT
Kiniksa Pharmaceuticals
KNSA
$6.31B
| $1.33M | 0.03% |
72,000
+42,000
| +140% | +$859K |
|
|
521
CALL
Kiniksa Pharmaceuticals
KNSA
$6.31B
| $1.33M | 0.03% |
71,800
+41,800
| +139% | +$855K |
|
522
PUT
Nike
NKE
$64.1B
| $1.33M | 0.03% |
10,000
+5,000
| +100% | +$695K |
|
523
CALL
Takeda Pharmaceutical
TAK
$56.7B
| $1.32M | 0.03% |
72,500
+67,500
| +1,350% | +$1.21M |
|
524
PUT
DoorDash
DASH
$84.3B
| $1.31M | 0.03% |
+10,000
| New | +$1.68M |
|
525
Snap
SNAP
$7.96B
| $1.31M | 0.03% |
+25,000
| New | +$1.44M |
|
Similar funds
EAM
CAM
CCM
GPCM
MAM
BGCI
TPL
RC
SG3 Management's Q1 2021 Portfolio in Review
As of Q1 2021, SG3 Management held 1,612 positions worth $4B, down 24% from $5.25B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
SG3 Management withdrew a net $1.28B in Q1 2021, closing 487 positions and reducing 208 holdings. Its most notable exit was Amazon, an estimated $294M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 1.8% of assets, up from 0.67% a quarter earlier, followed by Communication Services and Technology.
Against the trend, SG3 Management opened a new position in Albemarle worth $4.16M.
- SG3 Management's largest Q1 2021 buy was Albemarle: 28,500 shares worth $4.16M.
- SG3 Management added most to Jazz Pharmaceuticals in Q1 2021, an estimated $10.2M increase.
- SG3 Management's biggest Q1 2021 reduction was RH, cutting an estimated $25.1M.
- SG3 Management fully exited Amazon in Q1 2021, selling an estimated $294M.
- SG3 Management's ten largest holdings make up 21% of its $4B portfolio in Q1 2021.
- SG3 Management opened 626 new positions and closed 487 in Q1 2021.
- SG3 Management's portfolio value fell 24% quarter-over-quarter to $4B.
Based on SG3 Management's 13F filing for Q1 2021, filed 17 May 2021.